Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 164 citing articles:

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors
Mario Gennaro Mazza, Rebecca De Lorenzo, Caterina Conte, et al.
Brain Behavior and Immunity (2020) Vol. 89, pp. 594-600
Open Access | Times Cited: 1649
Major depressive disorder
Wolfgang Marx, Brenda W.J.H. Penninx, Marco Solmi, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 216
Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 200
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
Mario Gennaro Mazza, Mariagrazia Palladini, Sara Poletti, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 681-702
Open Access | Times Cited: 158
C-Reactive Protein as a Biomarker for Major Depressive Disorder?
Laura Orsolini, Simone Pompili, Silvia Tempia Valenta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1616-1616
Open Access | Times Cited: 82
Immunoregulatory role of the gut microbiota in inflammatory depression
Penghong Liu, Zhifen Liu, Jizhi Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 47
Inflammatory mediators in major depression and bipolar disorder
Sara Poletti, Mario Gennaro Mazza, Francesco Benedetti
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers
Sara Poletti, Raffaella Zanardi, Alessandra Mandelli, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 52-68
Open Access | Times Cited: 23
“Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression
Yishu Yin, Ting Ju, Deyong Zeng, et al.
Pharmacological Research (2024) Vol. 207, pp. 107322-107322
Open Access | Times Cited: 15
Unraveling the Complex Interplay Between Neuroinflammation and Depression: A Comprehensive Review
Andreea Sălcudean, Ramona Amina Popovici, D. E. Pitic, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1645-1645
Open Access | Times Cited: 2
Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
Nicole Leite Galvão‐Coelho, Ana Cecília de Menezes Galvão, Raíssa Nóbrega de Almeida, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 10, pp. 1125-1133
Closed Access | Times Cited: 103
Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: Systematic review and meta‐analysis
Christina M. van der Feltz‐Cornelis, Sarah Allen, R. I. G. Holt, et al.
Brain and Behavior (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 99
The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
Esmé Jansen van Vuren, Stephan F. Steyn, C. Brink, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 135, pp. 111200-111200
Open Access | Times Cited: 96
The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies
Vlad Dionisie, Gabriela Adriana Filip, Mihnea Costin Manea, et al.
Inflammopharmacology (2020) Vol. 29, Iss. 1, pp. 75-90
Closed Access | Times Cited: 88
Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression
Chotima Böttcher, Camila Fernández‐Zapata, Gijsje J. L. Snijders, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 71
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression
Maria S. Simon, Carmen Schiweck, Gara Arteaga-Henríquez, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110391-110391
Open Access | Times Cited: 71
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 1084-1117
Open Access | Times Cited: 68
Elevated peripheral inflammation is associated with attenuated striatal reward anticipation in major depressive disorder
Kaiping Burrows, Jennifer L. Stewart, Rayus Kuplicki, et al.
Brain Behavior and Immunity (2021) Vol. 93, pp. 214-225
Open Access | Times Cited: 65
Inflammation and depression in young people: a systematic review and proposed inflammatory pathways
Yara J. Toenders, Liliana Laskaris, Christopher G. Davey, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 315-327
Open Access | Times Cited: 59
Targeting inflammation: a potential approach for the treatment of depression
Shvetank Bhatt, Thangaraj Devadoss, Niraj Kumar Jha, et al.
Metabolic Brain Disease (2022) Vol. 38, Iss. 1, pp. 45-59
Closed Access | Times Cited: 48
Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications
Mandakh Bekhbat, Michael T. Treadway, Jennifer C. Felger
Current topics in behavioral neurosciences (2022), pp. 397-419
Closed Access | Times Cited: 41
Hyper-inflammation of astrocytes in patients of major depressive disorder: Evidence from serum astrocyte-derived extracellular vesicles
Xin‐hui Xie, Wentao Lai, Shu‐xian Xu, et al.
Brain Behavior and Immunity (2022) Vol. 109, pp. 51-62
Closed Access | Times Cited: 39
Antidepressant psychopharmacology: is inflammation a future target?
Francesco Benedetti, Raffaella Zanardi, Mario Gennaro Mazza
International Clinical Psychopharmacology (2022) Vol. 37, Iss. 3, pp. 79-81
Closed Access | Times Cited: 38
Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Jenessa N. Johnston, Maximillian Greenwald, Ioline D. Henter, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 4, pp. 103518-103518
Open Access | Times Cited: 36
Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses
Maria S. Simon, Gara Arteaga-Henríquez, Ahmed Fouad Algendy, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1-25
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top